Sarah E. Davidson
About
In The Last Decade
Sarah E. Davidson
6 papers receiving 47 citations
Peers
Comparison fields: 5 of 25
- Immunology 30
- Molecular Biology 13
- Radiology, Nuclear Medicine and Imaging 13
- Pathology and Forensic Medicine 8
- Oncology 7
Countries citing papers authored by Sarah E. Davidson
This map shows the geographic impact of Sarah E. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Davidson more than expected).
Fields of papers citing papers by Sarah E. Davidson
This network shows the impact of papers produced by Sarah E. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Davidson. The network helps show where Sarah E. Davidson may publish in the future.
Co-authorship network of co-authors of Sarah E. Davidson
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Davidson. A scholar is included among the top collaborators of Sarah E. Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Davidson. Sarah E. Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease. | 5 |
| 5 | 12 | |
| 6 | Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen. | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.